Literature DB >> 27677717

Liver cancer: IGF2 - an epigenetic oncodriver in HCC.

Hugh Thomas.   

Abstract

Entities:  

Year:  2016        PMID： 27677717     DOI： 10.1038/nrgastro.2016.162

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.

Authors:  Iris Martinez-Quetglas; Roser Pinyol; Daniel Dauch; Sara Torrecilla; Victoria Tovar; Agrin Moeini; Clara Alsinet; Anna Portela; Leonardo Rodriguez-Carunchio; Manel Solé; Amaia Lujambio; Augusto Villanueva; Swan Thung; Manel Esteller; Lars Zender; Josep M Llovet
Journal:  Gastroenterology       Date:  2016-09-07       Impact factor: 22.682
  1 in total
  3 in total

1.  Rapid 3D bioprinting of decellularized extracellular matrix with regionally varied mechanical properties and biomimetic microarchitecture.

Authors:  Xuanyi Ma; Claire Yu; Pengrui Wang; Weizhe Xu; Xueyi Wan; Cheuk Sun Edwin Lai; Justin Liu; Anna Koroleva-Maharajh; Shaochen Chen
Journal:  Biomaterials       Date:  2018-09-18       Impact factor: 12.479

Review 2.  The Curious Case of the HepG2 Cell Line: 40 Years of Expertise.

Authors:  Viktoriia A Arzumanian; Olga I Kiseleva; Ekaterina V Poverennaya
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

3.  Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma.

Authors:  Federica Ragusa; Nadia Panera; Silvia Cardarelli; Marco Scarsella; Marzia Bianchi; Stefano Biagioni; Mauro Giorgi; Anna Alisi; Mara Massimi
Journal:  Cancers (Basel)       Date:  2021-05-01       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.